169 related articles for article (PubMed ID: 35638310)
1. Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis.
Jordan KR; Wyatt CR; Fallon ME; Woltjer R; Neuwelt EA; Cheng Q; Gailani D; Lorentz C; Tucker EI; McCarty OJT; Hinds MT; Nguyen KP
J Thromb Haemost; 2022 Sep; 20(9):2035-2045. PubMed ID: 35638310
[TBL] [Abstract][Full Text] [Related]
2. Ferumoxytol-enhanced MRI assessment of venous Thrombus resolution and macrophage content in a murine deep vein thrombosis model.
Morrison L; Smoody B; Woltjer R; Hinds MT; Loftis JM; Wyatt CW; Nguyen KP
Thromb Res; 2024 Aug; 240():109063. PubMed ID: 38878741
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice.
Ngo ATP; Jordan KR; Mueller PA; Hagen MW; Reitsma SE; Puy C; Revenko AS; Lorentz CU; Tucker EI; Cheng Q; Hinds MT; Fazio S; Monia BP; Gailani D; Gruber A; Tavori H; McCarty OJT
J Thromb Haemost; 2021 Apr; 19(4):1001-1017. PubMed ID: 33421301
[TBL] [Abstract][Full Text] [Related]
4. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D
Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381
[TBL] [Abstract][Full Text] [Related]
5. Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial.
Lorentz CU; Verbout NG; Wallisch M; Hagen MW; Shatzel JJ; Olson SR; Puy C; Hinds MT; McCarty OJT; Gailani D; Gruber A; Tucker EI
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):799-809. PubMed ID: 30700130
[TBL] [Abstract][Full Text] [Related]
6. Model-dependent contributions of FXII and FXI to venous thrombosis in mice.
Grover SP; Olson TM; Cooley BC; Mackman N
J Thromb Haemost; 2020 Nov; 18(11):2899-2909. PubMed ID: 33094904
[TBL] [Abstract][Full Text] [Related]
7. Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model.
van Montfoort ML; Knaup VL; Marquart JA; Bakhtiari K; Castellino FJ; Hack CE; Meijers JC
Thromb Haemost; 2013 Nov; 110(5):1065-73. PubMed ID: 23925504
[TBL] [Abstract][Full Text] [Related]
8. Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.
Moaveni DK; Lynch EM; Luke C; Sood V; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2008 Mar; 47(3):616-24. PubMed ID: 18295113
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis.
Zhong C; Zhang L; Chen L; Deng L; Li R
J Thromb Haemost; 2017 Jan; 15(1):122-130. PubMed ID: 27813324
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates.
Crosby JR; Marzec U; Revenko AS; Zhao C; Gao D; Matafonov A; Gailani D; MacLeod AR; Tucker EI; Gruber A; Hanson SR; Monia BP
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1670-8. PubMed ID: 23559626
[TBL] [Abstract][Full Text] [Related]
11. Coagulation factor XI as a novel target for antithrombotic treatment.
Löwenberg EC; Meijers JC; Monia BP; Levi M
J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under endothelial denudation and/or blood stasis.
Takahashi M; Yamashita A; Moriguchi-Goto S; Sugita C; Matsumoto T; Matsuda S; Sato Y; Kitazawa T; Hattori K; Shima M; Asada Y
Thromb Res; 2010 May; 125(5):464-70. PubMed ID: 20089298
[TBL] [Abstract][Full Text] [Related]
13. The Formation of Microthrombi in Parenchymal Microvessels after Traumatic Brain Injury Is Independent of Coagulation Factor XI.
Schwarzmaier SM; de Chaumont C; Balbi M; Terpolilli NA; Kleinschnitz C; Gruber A; Plesnila N
J Neurotrauma; 2016 Sep; 33(17):1634-44. PubMed ID: 26886854
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet count in a murine stasis model of deep vein thrombosis.
Mathews R; Setthavongsack N; Le-Cook A; Kaempf A; Loftis JM; Woltjer RL; Lorentz CU; Revenko A; Hinds MT; Nguyen KP
Platelets; 2024 Dec; 35(1):2290916. PubMed ID: 38099327
[TBL] [Abstract][Full Text] [Related]
15. The hemostatic role of factor XI.
Puy C; Rigg RA; McCarty OJ
Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
[TBL] [Abstract][Full Text] [Related]
16. Deep vein thrombosis resolution is not accelerated with increased neovascularization.
Varma MR; Moaveni DM; Dewyer NA; Varga AJ; Deatrick KB; Kunkel SL; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2004 Sep; 40(3):536-42. PubMed ID: 15337885
[TBL] [Abstract][Full Text] [Related]
17. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK
J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119
[TBL] [Abstract][Full Text] [Related]
18. Factor XI and contact activation as targets for antithrombotic therapy.
Gailani D; Bane CE; Gruber A
J Thromb Haemost; 2015 Aug; 13(8):1383-95. PubMed ID: 25976012
[TBL] [Abstract][Full Text] [Related]
19. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.
Tucker EI; Marzec UM; White TC; Hurst S; Rugonyi S; McCarty OJ; Gailani D; Gruber A; Hanson SR
Blood; 2009 Jan; 113(4):936-44. PubMed ID: 18945968
[TBL] [Abstract][Full Text] [Related]
20. Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice.
Wang X; Smith PL; Hsu MY; Gailani D; Schumacher WA; Ogletree ML; Seiffert DA
J Thromb Haemost; 2006 Sep; 4(9):1982-8. PubMed ID: 16961605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
